This would suggest a greater specificity of CD105 than CD31 for assessing the tumor neo-vasculature [21,22], though CD31-assessed MVD performed well enough as a marker for it to still be useful, also due to its wider diffusion and better standardization. Here, PECAM1 is linked to neoplasm.